Tepkinly
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tepkinly, covering 2026-02-06 to 2026-08-06. Get the full timeline:
Most recent: EMA Authorised: Tepkinly (epcoritamab) — AbbVie Deutschland GmbH & Co. KG